New Mexico's cannabis retailers have recorded $2.35 billion in total sales since the state's adult-use market launched, with recreational purchases accounting for nearly three-quarters of all revenue, according to state data reported by the El Paso Times.
The milestone, reached in June 2026, breaks down to $1.7 billion in adult-use sales and $643 million in medical cannabis purchases. The figures underscore New Mexico's position as one of the Southwest's most active cannabis markets, particularly among states bordering prohibition jurisdictions.
Albuquerque leads the state in total sales volume as New Mexico's largest metropolitan area. But industry observers note that border communities have emerged as unexpected revenue centers, likely drawing customers from neighboring Texas, where cannabis remains illegal despite ongoing legislative debates.
Border Economics
The geographic distribution of sales points to a familiar pattern in states adjacent to prohibition markets. New Mexico shares a 180-mile border with Texas, where Republican legislative leadership has repeatedly blocked cannabis reform efforts despite polling showing majority support among Texas voters.
Cities like Sunland Park, Hobbs, and Clovis have reported robust dispensary activity since adult-use sales began in April 2022. The state's Regulation and Licensing Department has not released granular city-by-city breakdowns, but tax revenue data suggests border towns punch above their weight relative to population size.
Texas residents who cross state lines to purchase cannabis still face legal risks under their home state's laws, but enforcement has been inconsistent. Some Texas border counties have deprioritized low-level possession cases, while others maintain strict enforcement.
Medical Program Holds Steady
The $643 million in medical sales indicates New Mexico's medical program has retained a substantial patient base despite the availability of adult-use products. Medical cannabis in New Mexico carries lower tax rates and higher purchase limits, incentivizing patients with qualifying conditions to maintain their registrations.
New Mexico's medical program, established in 2007, covers conditions including PTSD, cancer, and chronic pain. The state has approximately 130,000 active medical cardholders, according to recent regulatory filings.
Adult-use sales tax revenue flows into the state's general fund as well as dedicated allocations for drug treatment programs and local governments. The state collects an excise tax of 12% on cannabis sales, plus standard gross receipts taxes that vary by municipality.
What's Next
New Mexico's cannabis market shows no signs of slowing. The state issued 34 new retail licenses in the first quarter of 2026, bringing the total number of dispensaries to over 400 statewide. Industry analysts project the state could reach $3 billion in cumulative sales by early 2027 if current growth rates continue.
The market faces potential headwinds from federal rescheduling discussions, which could alter the tax treatment of cannabis businesses under Section 280E. New Mexico retailers currently cannot deduct standard business expenses on federal tax returns, a restriction that would ease if cannabis moves to Schedule III as proposed by the DEA.
Meanwhile, Texas lawmakers are expected to consider cannabis legislation again in their 2027 session. A successful Texas legalization effort would likely reshape New Mexico's border market dynamics, though political observers give such bills low odds of passage in the Republican-controlled legislature.
This article is based on original reporting by ganjapreneur.com.
